Clinical Trials Map
The results of clinical trials suggest that psychedelics could be used for a range of therapeutic purposes, but figuring out how to participate in psychedelic-assisted therapy as either a therapist or a patient can be complicated. BCSP’s clinical trials map, featuring data from ClinicalTrials.gov, provides a way to navigate past, ongoing and future trials.
Psilocybin Versus Ketamine in Treatment-Resistant Depression
National Institute of Mental HealthKlecany, Czechia
Open Label Study of MDMA-assisted Psychotherapy for Treatment of PTSD With Optional fMRI Sub-Study
NUDZ – National Institute of Mental HealthKlecany, Středočeský Kraj, Czechia
Charité – Universitätsmedizin, Berlin Campus Benjamin FranklinBerlin, Germany
Stichting Centrum '45/ArqOegstgeest, Noord Holand, Netherlands
Sykehuset Østfold Hf, DPS NorderMoss, Norway
University Hospital of Wales – Research FacilityCardiff, United Kingdom
The Institute of Psychiatry, Psychology and NeuroscienceLondon, United Kingdom
Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant Depression
Draulio B de AraujoNatal, Rio Grande do Norte, Brazil
Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder
University of CalgaryCalgary, Alberta, Canada
Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion
Behavioral Biology Research Center, Johns Hopkins BayviewBaltimore, Maryland, United States
Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators
Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Medical CenterBaltimore, Maryland, United States
Neuronal Correlates of Altered States of Consciousness
University HospitalBasel, Switzerland
Effects of Repeated Psilocybin Dosing in OCD
Connecticut Mental Health CenterNew Haven, Connecticut, United States
Pilot Trial of Visual Healing® in Psilocybin-assisted Therapy for Alcohol Use Disorder
Pacific Treatment & Research in PsychedelicsSanta Monica, California, United States
Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of Consciousness
University Hospital Basel, Clinical Trial UnitBasel, BS, Switzerland
Page 1 of 26
How to use the clinical trials map
Clinical trials have provided growing evidence that ketamine, psilocybin, and MDMA can work in combination with therapy to help alleviate a range of mental disorders, including PTSD, depression, substance-use disorders, and anxiety. The field is advancing rapidly, but it can be difficult to navigate changing information to learn more about specific trials.
In the map view, explore clinical trials based on location. Click on a pink cluster or use the + button to zoom in on a particular location. Click on a smaller pink dot to access an overview of a particular clinical trial, including the substance, the phase, and relevant conditions. Click on the “Full Trial Record” link to learn more about the trial on the ClinicalTrials.gov site.
In the list view, the clinical trials tracker offers a tool for researchers and clinicians to quantify and explore trials based on a number of factors. Click on “Filter” to see relevant trials based on substance, trial status, study phase and more. Where the list shows closed trials users are able explore published results, including searching by institution.